Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus dexmedetomidine for sedation during awake fibreoptic nasal intubation
ChiCTR2000031965Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam and dexmedetomidine in difficult airway (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Intubation comfort. Started Dec 2020; status: completed.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
difficult airway
Beyond the preview
Go deeper on ChiCTR2000031965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031965.